Form 4: H.B. Fuller Executive Campe Exercises Options and Sells Shares

Sentiment:

SEC Form 4 Filing


Heather Campe, Sr. VP of International Growth at H.B. Fuller, exercised stock options and sold shares on July 12, 2024.

Summary

  • Heather Campe, a Senior Vice President at H.B. Fuller, executed transactions involving the company's stock on July 12, 2024.
  • Campe exercised employee stock options to acquire 23,696 shares of common stock at a price of $50.10 per share.
  • Simultaneously, Campe sold 23,696 shares of common stock at a weighted average price of $82.6622, with prices ranging from $82.4250 to $82.81.
  • Following these transactions, Campe directly owns 19,741.79 shares of H.B. Fuller common stock.
  • Campe also holds derivative securities including employee stock options and restricted stock units.

Sentiment

Score: 5

Explanation: This is a routine disclosure of insider trading activity. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information about transactions.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider activity and can be monitored for insights into management's perspective on the company's valuation and future prospects. Similar filings are common across all publicly traded companies.

Comparison to Industry Standards

  • Comparing H.B. Fuller's executive compensation and stock option plans to those of its peers in the specialty chemicals industry, such as Avery Dennison or RPM International, would provide context on whether these transactions are typical.
  • Analyzing the vesting schedules and exercise prices of the options against industry benchmarks can reveal if they are aligned with standard practices for incentivizing executive performance.
  • The average sale price of $82.6622 can be compared to the trading volume and price volatility of FUL stock on July 12, 2024, to assess the impact of this transaction on the market.

Key Dates

DateDescription
01/26/2018Date from which employee stock options at $50.10 are exercisable.
01/25/2019Date from which employee stock options at $53.57 are exercisable.
01/24/2023Date from which employee stock options at $72.94 are exercisable and restricted stock units vest.
01/27/2022Date from which employee stock options at $51.89 are exercisable.
01/24/2024Date from which employee stock options at $68.17 are exercisable and restricted stock units vest.
01/26/2025Date from which employee stock options at $77.72 are exercisable and restricted stock units vest.
01/24/2025Expiration date for restricted stock units.
01/24/2026Expiration date for restricted stock units.
01/26/2027Expiration date for restricted stock units and employee stock options at $50.10.
01/25/2028Expiration date for employee stock options at $53.57.
01/27/2031Expiration date for employee stock options at $51.89.
01/24/2032Expiration date for employee stock options at $72.94.
01/24/2033Expiration date for employee stock options at $68.17.
01/26/2034Expiration date for employee stock options at $77.72.
07/12/2024Date of the stock option exercise and share sale.
07/15/2024Date of the form filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.